FDA Eli Lilly - Search News

Eli Lilly takes aim at weight-loss drug copies

Reuters on MSN · 20h

Eli Lilly takes aim at weight-loss drug copies with new ad campaign

Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its latest attempt to fend off competition from copies of its weight-loss drug. The ad,

InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing measles outbreak in Texas,

The Washington Post on MSN · 2d

Eli Lilly says it will spend billions to move drug manufacturing to U.S. soil

Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, part of a doubling of its investment in manufacturing.

3don MSN

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

2don MSN

Eli Lilly plans to invest $27B to build four new US plants as tariffs loom

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results